| |
|
|
|
Richard Wallace
BCom, BCom(Hons)
Richard J Wallace has joined the Bridgehead Board
as a Non-Executive Director, following 15 years at GlaxoSmithKline
(GSK), where he was most recently Senior Vice President of Global
Product Strategy, accountable for Global Health Outcomes, Scientific
Communications, Global Commercial Strategy and Business & Commercial
Analysis. He also served as a member of its Research and Development
Executive, Commercial Operations Committee, Product Management Board
and Scientific Advisory Board. During his years at GSK and its heritage
companies, Richard held positions from Vice President Commercial
(Canadian Pharmaceuticals), Vice President U.S. Business Development,
Vice President Sales & Marketing (U.S. Oncology and HIV), Vice
President Clinical Development and Product Strategy, and Vice President
of Global Commercial Strategy.
His experience prior to joining GSK included eight
years with Bristol-Myers Squibb and seven years at Johnson &
Johnson in assignments from Marketing, Sales, Manufacturing and
General Management.
Richard received BCom and BCom(Hons) degrees from Rhodes University,
South Africa and currently serves on the board of directors of Avigen
Inc, ImmunoGen Inc and Clinical Data Inc.
Top
|
